{"id":3598,"date":"2021-02-08T07:45:39","date_gmt":"2021-02-08T13:45:39","guid":{"rendered":"http:\/\/blogs.luc.edu\/compliance\/?p=3598"},"modified":"2021-02-08T07:45:39","modified_gmt":"2021-02-08T13:45:39","slug":"politicizing-a-pandemic-emergency-use-authorizations-for-covid-19","status":"publish","type":"post","link":"https:\/\/blogs.luc.edu\/compliance\/?p=3598","title":{"rendered":"Politicizing a Pandemic: Emergency Use Authorizations for COVID-19"},"content":{"rendered":"<p><i style=\"font-family: 'times new roman', times, serif\">Joanna Shea<br \/>\n<\/i><span style=\"font-family: 'times new roman', times, serif\"><i>Associate Editor<br \/>\n<\/i><\/span><span style=\"font-family: 'times new roman', times, serif\">Loyola University Chicago, School of Jaw, JD 2022<\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\">The Food and Drug Administration (\u201cFDA\u201d) is one regulatory agency that has been on the forefront of the American fight against COVID-19. Historically, the agency has been highly respected for its success in apolitical operation despite <a href=\"https:\/\/www.fda.gov\/about-fda\/what-we-do\"><span class=\"s1\">its mission<\/span><\/a> of (1) protecting the public health and (2) innovating in the development of medical products. One of its most important tools in the face of a public health crisis is the once obscure regulatory mechanism called the Emergency Use Authorization (\u201cEUA\u201d). But as <a href=\"https:\/\/www.npr.org\/2020\/09\/25\/917014322\/trust-in-cdc-and-fda-is-at-a-low\"><span class=\"s1\">public trust<\/span><\/a> in the FDA falters, Americans are surely wondering how effective a protective measure can be when it seems to be used as political ammo.<\/span><\/p>\n<p><!--more--><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\"><b>The FDA\u2019s place in all of this<\/b><\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\"><a href=\"https:\/\/www.fda.gov\/about-fda\/fda-organization\"><span class=\"s1\">Organizationally<\/span><\/a>, the FDA is an executive agency organized under the Department of Health and Human Services (\u201cHHS\u201d). Especially for such a robust and powerful agency, this hierarchical structure poses a unique, but until now, relatively unprovoked opportunity for tension between the Commissioner of the FDA and the Secretary of HHS. However, these are indeed unprecedented times, and even the FDA has <a href=\"https:\/\/www.politico.com\/news\/2020\/10\/22\/azar-plans-oust-hahn-fda-431139\"><span class=\"s1\">become politicized<\/span><\/a>. <span class=\"Apple-converted-space\">\u00a0 \u00a0<\/span><\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\"><b>What exactly is an Emergency Use Authorization (\u201cEUA\u201d)?\u00a0<\/b><\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\">An <a href=\"https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-legal-regulatory-and-policy-framework\/emergency-use-authorization\"><span class=\"s1\">EUA is a mechanism<\/span><\/a> to strengthen public health protections in the face of a public health crisis, like the current COVID-19 pandemic. As amended by Project Bioshield Act of 2004, <a href=\"https:\/\/www.astho.org\/Programs\/Preparedness\/Public-Health-Emergency-Law\/Emergency-Use-Authorization-Toolkit\/Section-564-of-the-Federal-Food,-Drug,-and-Cosmetic-Act-Fact-Sheet\/\"><span class=\"s1\">Section 564<\/span><\/a> of the Food, Drug &amp; Cosmetics Act <a href=\"https:\/\/www.federalregister.gov\/documents\/2005\/02\/02\/05-2028\/authorization-of-emergency-use-of-anthrax-vaccine-adsorbed-for-prevention-of-inhalation-anthrax-by\"><span class=\"s1\">allows the FDA commissioner<\/span><\/a> to issue an EUA to address certain types of emergencies. This regulatory tool allows the FDA to authorize the use of an unapproved medical product or of an approved medical product for unapproved uses when there are no adequate or approved alternatives.<\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\">Unlike typical FDA authorizations, the EUA approval process allows the FDA to use <i>available<\/i> information to balance risks of the unproven products with any known benefits. An EUA can only be granted in a declared state of national emergency and is not a substitute for a standard approval. Although the FDA <a href=\"https:\/\/www.fda.gov\/vaccines-blood-biologics\/development-approval-process-cber\/vaccine-development-101\"><span class=\"s1\">doesn\u2019t proscribe a timeline<\/span><\/a> for typical vaccine development, EUA approval is intentionally expedited in comparison.<\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\">On December 11, 2020, the FDA\u2019s advisory committee <a href=\"https:\/\/www.cnn.com\/world\/live-news\/coronavirus-pandemic-12-11-20-intl\/index.html\"><span class=\"s1\">recommended<\/span><\/a> the Pfizer vaccine be granted EUA status. The FDA has only granted an EUA for a vaccine once before for Anthrax vaccine Adsorbed. Ultimately, it was revoked.<\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\"><b>Remember hydrochloride? Yeah, that was an EUA\u2026<\/b><\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\">In their very nature, EUAs are subject to skepticism. Paired with <a href=\"https:\/\/www.nytimes.com\/2020\/10\/10\/health\/covid-vaccine-treatment-fda-emergency.html\"><span class=\"s1\">errant statements<\/span><\/a> from a rhetoric-heavy president, they stand to lose all credibility. While the FDA has granted EUAs in past disease outbreaks like H1NI flu in 2009 and Zika in 2016, COVID-19 response has generated an unprecedented 300 EUAs since February 2020.\u00a0<\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\">One now infamous product, antimalarial drug hydroxychloroquine, received an EUA which was <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and\"><span class=\"s1\">revoked<\/span><\/a> shortly thereafter. If not for then-President Trump\u2019s <a href=\"https:\/\/www.nytimes.com\/2020\/05\/18\/us\/politics\/trump-hydroxychloroquine-covid-coronavirus.html\"><span class=\"s1\">wholehearted endorsement<\/span><\/a>, the EUA may have come and gone with relatively little attention. But instead, medical experts and the public alike condemned the apparent politicization of the drug.<\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\">The FDA has since <a href=\"https:\/\/apnews.com\/article\/donald-trump-business-mark-meadows-coronavirus-pandemic-0902fbb041b0459e55da86be75b1457a\"><span class=\"s1\">received criticism<\/span><\/a> from the White House and directly from former President Trump through Twitter (although the posts have since been redacted). Shortly thereafter, the Trump administration resisted the <a href=\"https:\/\/www.politico.com\/news\/2020\/09\/28\/fda-vaccine-guidance-may-not-be-released-422648\"><span class=\"s1\">FDAs announcement<\/span><\/a> of revamped vaccine authorization guidance concurrent with a push from the Trump Administration to get a vaccine approved <a href=\"https:\/\/www.vox.com\/2020\/9\/8\/21419912\/covid-19-vaccine-coronavirus-fda-cdc-election-2020-trump\"><span class=\"s1\">before Election Day<\/span><\/a>. The problematic political pressure exerted on the FDA\u2019s decision making process regarding COVID drugs had <a href=\"https:\/\/www.biocentury.com\/article\/629725\"><span class=\"s1\">raised concerns<\/span><\/a> about the agency\u2019s ability to <a href=\"https:\/\/www.statnews.com\/2020\/08\/24\/newcomer-stephen-hahn-agency-seige\/\"><span class=\"s1\">operate impartially<\/span><\/a>.\u00a0<\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\"><b>Great, there is a vaccine. Will it work? <\/b><\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\">Creation of a vaccine is only half the battle. It\u2019s not easy to get it to where it needs to go, and at the (cold &#8211; <a href=\"https:\/\/www.npr.org\/sections\/health-shots\/2020\/11\/17\/935563377\/why-does-pfizers-covid-19-vaccine-need-to-be-kept-colder-than-antarctica\">very cold<\/a><span class=\"s1\">)<\/span> temperatures it needs to stay at. Cities have <a href=\"https:\/\/www.npr.org\/sections\/health-shots\/2021\/01\/29\/962143659\/in-philadelphia-a-scandal-erupts-over-vaccination-start-up-led-by-22-year-old\"><span class=\"s1\">unintentionally mis-stepped<\/span><\/a> in finding adequate partners for distribution. And historically, people are <a href=\"https:\/\/www.vox.com\/coronavirus-covid19\/22163315\/covid-19-vaccines-doses-pfizer-moderna\"><span class=\"s1\">really bad<\/span><\/a> at following up for a second dose of a two-part vaccine.<\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\">There is a lesson to be learned from all of this. Clearly, the FDA has limited safeguards against a President or HHS secretary from meddling for political influence. To prevent this from happening again, Congress could potentially <a href=\"https:\/\/jamanetwork.com\/channels\/health-forum\/fullarticle\/2771202\"><span class=\"s1\">insulate<\/span><\/a> the FDA similar to the structures of agencies like the Federal Trade Commission. For example, the FDA <a href=\"https:\/\/jamanetwork.com\/channels\/health-forum\/fullarticle\/2771202\"><span class=\"s1\">could be moved<\/span><\/a> from under the watchful gaze of the HHS. Alternatively, the FDA commissioner could only be replaced during their terms \u201cfor cause\u201d in efforts to shield them from the whims of the Commander-In-Chief.<\/span><\/p>\n<p class=\"p3\"><span style=\"font-family: 'times new roman', times, serif\">Hopefully Americans everywhere can contemplate this over a cocktail of fully approved COVID-19 vaccines in the coming months.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Food and Drug Administration (\u201cFDA\u201d) is one regulatory agency that has been on the forefront of the American fight against COVID-19. Historically, the agency has been highly respected for its success in apolitical operation despite its mission of (1) protecting the public health and (2) innovating in the development of medical products. One of its most important tools in the face of a public health crisis is the once obscure regulatory mechanism called the Emergency Use Authorization (\u201cEUA\u201d). But as public trust in the FDA falters, Americans are surely wondering how effective a protective measure can be when it seems to be used as political ammo.<\/p>\n","protected":false},"author":54,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[533,767,810,1205],"class_list":["post-3598","post","type-post","status-publish","format-standard","hentry","category-pharma-industry","tag-covid","tag-eua","tag-fda","tag-journal-of-regulatory-compliance"],"_links":{"self":[{"href":"https:\/\/blogs.luc.edu\/compliance\/index.php?rest_route=\/wp\/v2\/posts\/3598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.luc.edu\/compliance\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.luc.edu\/compliance\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.luc.edu\/compliance\/index.php?rest_route=\/wp\/v2\/users\/54"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.luc.edu\/compliance\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3598"}],"version-history":[{"count":0,"href":"https:\/\/blogs.luc.edu\/compliance\/index.php?rest_route=\/wp\/v2\/posts\/3598\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.luc.edu\/compliance\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.luc.edu\/compliance\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.luc.edu\/compliance\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}